Cargando…
OR20-5 28-Day Dosing with Avexitide Improves Hyperinsulinemic Hypoglycemia in Patients with Severe, Refractory Post-Bariatric Hypoglycemia: The PREVENT Study
Avexitide (formerly exendin 9-39) is a first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist in development as a liquid formulation for subcutaneous (SC) injection for treatment of post-bariatric hypoglycemia (PBH). PBH, a rare disease with high unmet medical need and no approved pharma...
Autores principales: | Lee, Clare, Lawler, Helen, Tan, Marilyn, Davis, Dawn, Tong, Jenny, Glodowski, Michele, Rogowitz, Elisa, Lamendola, Cindy, Karaman, Rowan, Dar, Moahad, Porter, Lisa, Craig, Colleen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554793/ http://dx.doi.org/10.1210/js.2019-OR20-5 |
Ejemplares similares
-
MON-599 Post-Bariatric Hypoglycemia: A Clinical Vignette on an Increasingly Recognized Disease
por: Farahmand, Abtin Kevin, et al.
Publicado: (2020) -
PREVENT: A Randomized, Placebo-controlled Crossover Trial of Avexitide for Treatment of Postbariatric Hypoglycemia
por: Craig, Colleen M, et al.
Publicado: (2021) -
FRI080 Post Bariatric Hypoglycemia And Pregnancy: Successful Utilization Of Remnant Stomach Gastrostomy Tube Placement In Severe Refractory Hypoglycemia After Roux-en-Y Gastric Bypass Surgery
por: Habbsa, Samima Sultana, et al.
Publicado: (2023) -
Refractory Hypoglycemia Related to Gastric Bypass Complicated by Hypothyroidism
por: Jain, Akhil, et al.
Publicado: (2021) -
SAT661 Bypass-oma Or Medication-oma: A Clinical Dilemma About Hypoglycemia
por: Perez Hernandez, Carlos Alberto, et al.
Publicado: (2023)